Sweden vs Zambia: Access to anti-retroviral drugs, male
Sweden
95.0%
in 2022
Zambia
95.0%
in 2024
Sweden rank
4th
Zambia rank
4th
Access to anti-retroviral drugs, male over time
- Sweden
- Zambia
How they compare
Sweden currently reports 95.0% against 95.0% in Zambia, a difference of 0.0%.
Across all 23 years both countries report, Sweden has been ahead every year.
Sweden ranks 4th and Zambia ranks 4th of 141 countries.
Sweden has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Sweden | Zambia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 53.7% | 10.7% | 43.0% | Sweden |
| 2010s | 92.5% | 60.6% | 31.9% | Sweden |
| 2020s | 95.3% | 89.7% | 5.7% | Sweden |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Sweden or Zambia?
- Sweden, at 95.0% against 95.0% in Zambia as of 2022.
- What is the difference in access to anti-retroviral drugs, male between Sweden and Zambia?
- 0.0%, with Sweden ahead.
- How many years of comparable data are there for Sweden and Zambia?
- 23 years are reported by both, from 2000 to 2022.
- How do Sweden and Zambia rank globally for access to anti-retroviral drugs, male?
- Sweden ranks 4th and Zambia ranks 4th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.